Orphan problems can snatch defeat from the jaws of victory on your complex technical and construction projects. These problems fall into the cracks between disciplines - they are "orphans" and often undetected or ignored until critical. Biotech and pharmaceutical companies frequently encounter such problems especially when building a new laboratory or facility or scaling up from the bench to a pilot plant or from pilot plant to production manufacturing.
An entirely new class of problems can arise that are not really part of pharmaceuticals or construction. GSC has focused on pharmaceutical companies since the 1980s. We understand FDA/DMP/GLP regulations and culture. We also understand construction. We can make them mesh. Other industries - power generation - transportation - instrumentation: medical, scientific, forensic - automated manufacturing and warehousing - computer manufacturing - and more - often encounter orphan problems and GSC has helped there also.
Showstopper problems - Orphan problems can be critical.
An entirely new class of problems can arise that are not really part of pharmaceuticals or construction. GSC has focused on pharmaceutical companies since the 1980s. We understand FDA/DMP/GLP regulations and culture. We also understand construction. We can make them mesh. Other industries - power generation - transportation - instrumentation: medical, scientific, forensic - automated manufacturing and warehousing - computer manufacturing - and more - often encounter orphan problems and GSC has helped there also.
Showstopper problems - Orphan problems can be critical.
Reviews
Be the first to review GSC Engineering.
Write a Review
